The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2020

Filed:

Apr. 06, 2017
Applicants:

Institut Pasteur, Paris, FR;

Inserm (Institut National DE LA Sante ET DE LA Recherche Medicale), Paris, FR;

Inventors:

Pierre Langlade-Demoyen, Paris, FR;

Fransisco Garcia Pons, Maurepas, FR;

Olivier Adotevi, Nogent sur Marne, FR;

Sylvain Cardinaud, Carrieres sur Seine, FR;

Christine Neuveut, Arcueil, FR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C12N 9/12 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 9/1276 (2013.01); A61K 39/0011 (2013.01); C12N 9/1241 (2013.01); A61K 38/00 (2013.01); A61K 2039/5154 (2013.01); A61K 2039/572 (2013.01); A61K 2039/605 (2013.01);
Abstract

This invention relates to the field of anticancer therapy, and to the identification of immunogenic peptides derived from the human telomerase reverse transcriptase (hTERT). The present invention relates to polynucleotides encoding hTERT epitopes restricted to MHC class I molecule, analogues thereof and polyepitopes containing such epitopes and/or analogues. Are also included in the present invention, vector and cell comprising such polynucleotides. The present invention also concerns composition comprising hTERT polypeptides, corresponding polynucleotides, vectors and cells, for use in the treatment and/or prevention of cancer.


Find Patent Forward Citations

Loading…